Showing results (821-830 of 6,996) with videos related to
Sort By:
Pageof 700
Cancer Science|January 15, 2005
Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiationHitoshi Tsuda, Daisaku Morita, Mikihiko Kimura, et al.Cancer Science|October 9, 2004
Estrogen enhancement of androgen-responsive gene expression in hormone-induced hyperplasia in the ventral prostate of F344 ratsNariaki Fujimoto, Tomoharu Suzuki, Hiroaki Honda, et al.Cancer Science|October 9, 2004
c-kit gene mutations in intracranial germinomasYuji Sakuma, Shinji Sakurai, Sachiko Oguni, et al.Cancer Science|October 9, 2004
Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancerHiroyuki Achiwa, Tetsuya Oguri, Shigeki Sato, et al.Cancer Science|October 20, 2005
Modeling human colon cancer in rodents using a food-borne carcinogen, PhIPHitoshi Nakagama, Masako Nakanishi, Masako OchiaiCancer Science|October 20, 2005
Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lungWei-Xia Peng, Tatsuhiro Shibata, Hiroto Katoh, et al.Cancer Science|October 20, 2005
Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma developmentAki Shimada, Junko Kano, Tadashi Ishiyama, et al.Cancer Science|October 20, 2005
Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 daysYasuhide Yamada, Noboru Yamamoto, Tatsu Shimoyama, et al.Cancer Science|January 14, 2010
Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasiaKonstantinos Mavridis, Margaritis Avgeris, Georgios Koutalellis, et al.Cancer Science|January 14, 2010
Augmentation of 3-methylcholanthrene-induced bioactivation in the human hepatoma cell line HepG2 by the calcium channel blocker nicardipineTakuomi Hosaka, Masashi Sekimoto, Kiyomitsu Nemoto, et al.Pageof 700